Acta Pharmaceutica Sinica B (May 2018)

The combined therapeutic effects of 131iodine-labeled multifunctional copper sulfide-loaded microspheres in treating breast cancer

  • Qiufang Liu,
  • Yuyi Qian,
  • Panli Li,
  • Sihang Zhang,
  • Zerong Wang,
  • Jianjun Liu,
  • Xiaoguang Sun,
  • Michael Fulham,
  • Dagan Feng,
  • Zhigang Chen,
  • Shaoli Song,
  • Wei Lu,
  • Gang Huang

Journal volume & issue
Vol. 8, no. 3
pp. 371 – 380

Abstract

Read online

Compared to conventional cancer treatment, combination therapy based on well-designed nanoscale platforms may offer an opportunity to eliminate tumors and reduce recurrence and metastasis. In this study, we prepared multifunctional microspheres loading 131I-labeled hollow copper sulfide nanoparticles and paclitaxel (131I-HCuSNPs-MS-PTX) for imaging and therapeutics of W256/B breast tumors in rats. 18F-fluordeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) imaging detected that the expansion of the tumor volume was delayed (P<0.05) following intra-tumoral (i.t.) injection with 131I-HCuSNPs-MS-PTX plus near-infrared (NIR) irradiation. The immunohistochemical analysis further confirmed the anti-tumor effect. The single photon emission computed tomography (SPECT)/photoacoustic imaging mediated by 131I-HCuSNPs-MS-PTX demonstrated that microspheres were mainly distributed in the tumors with a relatively low distribution in other organs. Our results revealed that 131I-HCuSNPs-MS-PTX offered combined photothermal, chemo- and radio-therapies, eliminating tumors at a relatively low dose, as well as allowing SPECT/CT and photoacoustic imaging monitoring of distribution of the injected agents non-invasively. The copper sulfide-loaded microspheres, 131I-HCuSNPs-MS-PTX, can serve as a versatile theranostic agent in an orthotopic breast cancer model. KEY WORDS: Microspheres, Theranostics, Combination therapy, Single photon emission computed tomography/computed tomography (SPECT/CT), Photoacoustic imaging